Literature DB >> 22610239

Immune to addiction: the ethical dimensions of vaccines against substance abuse.

Michael J Young1, Dominic A Sisti, Hila Rimon-Greenspan, Jason L Schwartz, Arthur L Caplan.   

Abstract

Promising advances have been made in recent years for a unique class of immunotherapies that use vaccination to combat substance-use disorders. Although such vaccines are potentially useful for addictions, they raise a variety of ethical and social questions.

Mesh：

Substances：

Year:  2012        PMID： 22610239     DOI： 10.1038/ni.2321

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  18 in total

1.  Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001.

Authors:  Megan S O'Brien; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

Review 2.  The neurobiology of addiction: implications for voluntary control of behavior.

Authors:  Steven E Hyman
Journal:  Am J Bioeth       Date:  2007-01       Impact factor: 11.229

3.  Human therapeutic cocaine vaccine: safety and immunogenicity.

Authors:  Thomas R Kosten; Marc Rosen; Julian Bond; Michael Settles; John St Clair Roberts; John Shields; Lindsay Jack; Barbara Fox
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

Review 4.  Addictive drugs and their relationship with infectious diseases.

Authors:  Herman Friedman; Susan Pross; Thomas W Klein
Journal:  FEMS Immunol Med Microbiol       Date:  2006-08

Review 5.  Immunotherapy for the treatment of drug abuse.

Authors:  Thomas Kosten; S Michael Owens
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

Review 6.  Substance abuse vaccines.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Tracie Gardner; Thomas R Kosten
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Suppression of psychoactive effects of cocaine by active immunization.

Authors:  M R Carrera; J A Ashley; L H Parsons; P Wirsching; G F Koob; K D Janda
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

8.  Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans.

Authors:  Margaret Haney; Erik W Gunderson; Huiping Jiang; Eric D Collins; Richard W Foltin
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

9.  Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.

Authors:  W Hall; L Carter
Journal:  J Med Ethics       Date:  2004-08       Impact factor: 2.903

10.  Abnormal brain structure implicated in stimulant drug addiction.

Authors:  Karen D Ersche; P Simon Jones; Guy B Williams; Abigail J Turton; Trevor W Robbins; Edward T Bullmore
Journal:  Science       Date:  2012-02-03       Impact factor: 47.728
View more
  7 in total

Review 1.  Biologic Approaches to Treat Substance-Use Disorders.

Authors:  Phil Skolnick
Journal:  Trends Pharmacol Sci       Date:  2015-10       Impact factor: 14.819

Review 2.  Immunotherapy Applied to Neuropsychiatric Disorders: a New Perspective of Treatment.

Authors:  Pedro Luis Prior
Journal:  J Mol Neurosci       Date:  2015-05-31       Impact factor: 3.444

3.  Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence.

Authors:  Anna Carfora; Paola Cassandro; Alessandro Feola; Francesco La Sala; Raffaella Petrella; Renata Borriello
Journal:  J Bioeth Inq       Date:  2018-01-19       Impact factor: 1.352

4.  Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.

Authors:  M L Miller; S M Aarde; A Y Moreno; K M Creehan; K D Janda; M A Taffe
Journal:  Drug Alcohol Depend       Date:  2015-06-19       Impact factor: 4.492

Review 5.  Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse.

Authors:  Emma Cahill; Marine Salery; Peter Vanhoutte; Jocelyne Caboche
Journal:  Front Pharmacol       Date:  2014-01-08       Impact factor: 5.810

6.  Pharmacy stakeholder reports on ethical and logistical considerations in anti-opioid vaccine development.

Authors:  Vincent Wartenweiler; Grace Chung; Amy Stewart; Cody Wenthur
Journal:  BMC Med Ethics       Date:  2021-03-25       Impact factor: 2.652

Review 7.  Vaccines against Drug Abuse-Are We There Yet?

Authors:  Benedict T Bloom; Mary-Jessimine Bushell
Journal:  Vaccines (Basel)       Date:  2022-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.